G
Gregory Pepper
Researcher at University of Washington
Publications - 22
Citations - 1278
Gregory Pepper is an academic researcher from University of Washington. The author has contributed to research in topics: Medicine & Viral load. The author has an hindex of 10, co-authored 19 publications receiving 963 citations.
Papers
More filters
Journal ArticleDOI
Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho.
Andrew Bryan,Gregory Pepper,Mark H. Wener,Susan L. Fink,Chihiro Morishima,Anu Chaudhary,Keith R. Jerome,Keith R. Jerome,Patrick C. Mathias,Alexander L. Greninger,Alexander L. Greninger +10 more
TL;DR: It is expected that the availability of high-quality serological testing will be a key tool in the fight against SARS-CoV-2 as the limited circulation of the virus in the western United States.
Journal ArticleDOI
Cryptic transmission of SARS-CoV-2 in Washington state.
Trevor Bedford,Trevor Bedford,Alexander L. Greninger,Alexander L. Greninger,Pavitra Roychoudhury,Pavitra Roychoudhury,Lea M. Starita,Michael Famulare,Meei-Li Huang,Meei-Li Huang,Arun K. Nalla,Gregory Pepper,Adam Reinhardt,Hong Xie,Lasata Shrestha,Truong N. Nguyen,Amanda Adler,Elisabeth Brandstetter,Shari Cho,Danielle Giroux,Peter D Han,Kairsten Fay,Chris D. Frazar,Misja Ilcisin,Kirsten Lacombe,Jover Lee,Anahita Kiavand,Matthew Richardson,Thomas R. Sibley,Melissa Truong,Caitlin R Wolf,Deborah A. Nickerson,Mark J. Rieder,Janet A. Englund,Janet A. Englund,James Hadfield,Emma B. Hodcroft,Emma B. Hodcroft,John Huddleston,John Huddleston,Louise H. Moncla,Nicola F. Müller,Richard A. Neher,Richard A. Neher,Xianding Deng,Wei Gu,Scot Federman,Charles Y. Chiu,Jeffrey S. Duchin,Jeffrey S. Duchin,Romesh Gautom,Geoff Melly,Brian Hiatt,Philip Dykema,Scott Lindquist,Krista Queen,Ying Tao,Anna Uehara,Suxiang Tong,Duncan MacCannell,Gregory L. Armstrong,Geoffrey S. Baird,Helen Y. Chu,Jay Shendure,Jay Shendure,Keith R. Jerome,Keith R. Jerome +66 more
TL;DR: It is found that most SARS-CoV-2 infections sampled during this time derive from a single introduction in late January or early February 2020, which subsequently spread locally before active community surveillance was implemented.
Posted ContentDOI
Cryptic transmission of SARS-CoV-2 in Washington State.
Trevor Bedford,Trevor Bedford,Alexander L. Greninger,Alexander L. Greninger,Pavitra Roychoudhury,Pavitra Roychoudhury,Lea M. Starita,Michael Famulare,Meei-Li Huang,Arun K. Nalla,Gregory Pepper,Adam Reinhardt,Hong Xie,Lasata Shrestha,Truong N. Nguyen,Amanda L. Adler,Elisabeth Brandstetter,Shari Cho,Danielle Giroux,Peter D Han,Kairsten Fay,Chris D. Frazar,Misja Ilcisin,Kirsten Lacombe,Jover Lee,Anahita Kiavand,Matthew Richardson,Thomas R. Sibley,Melissa Truong,Caitlin R Wolf,Deborah A. Nickerson,Mark J. Rieder,Janet A. Englund,Janet A. Englund,Seattle Flu Study Investigators,James Hadfield,Emma B. Hodcroft,John Huddleston,John Huddleston,Louise H. Moncla,Nicola F. Müller,Richard A. Neher,Xianding Deng,Wei Gu,Scot Federman,Charles Y. Chiu,Jeff Duchin,Jeff Duchin,Romesh Gautom,Geoff Melly,Brian Hiatt,Philip Dykema,Scott Lindquist,Krista Queen,Ying Tao,Anna Uehara,Suxiang Tong,Duncan MacCannell,Gregory L. Armstrong,Geoffrey S. Baird,Helen Y. Chu,Jay Shendure,Jay Shendure,Keith R. Jerome,Keith R. Jerome +64 more
TL;DR: The large majority of SARS-CoV-2 infections sampled during this time frame appeared to have derived from a single introduction event into the state in late January or early February 2020 and subsequent local spread, strongly suggesting cryptic spread of COVID-19 during the months of January and February 2020, before active community surveillance was implemented.
Journal ArticleDOI
Rapid and Sensitive Oligonucleotide Ligation Assay for Detection of Mutations in Human Immunodeficiency Virus Type 1 Associated with High-Level Resistance to Protease Inhibitors
Ingrid A. Beck,Madhumita Mahalanabis,Gregory Pepper,Amy Wright,Shannon Hamilton,Erika Langston,Lisa M. Frenkel +6 more
TL;DR: This rapid, simple, economical, and highly sensitive assay provides a practical alternative to dideoxy sequencing for genotypic evaluation of HIV-1 resistance to antiretrovirals.
Posted ContentDOI
Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence Testing in Idaho
Andrew Bryan,Gregory Pepper,Mark H. Wener,Susan L. Fink,Chihiro Morishima,Anu Chaudhary,Keith R. Jerome,Patrick C. Mathias,Alexander L. Greninger +8 more
TL;DR: These data demonstrate excellent analytical performance of the Abbott SARS-CoV-2 IgG test as well as the limited circulation of the virus on the West Coast, and expect the availability of high-quality serological testing will be a key tool in the fight against Sars-Cov-2.